Filing Details

Accession Number:
0001437749-17-001931
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-08 16:47:09
Reporting Period:
2017-02-07
Filing Date:
2017-02-08
Accepted Time:
2017-02-08 16:47:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820081 Cambrex Corp CBM Pharmaceutical Preparations (2834) 222476135
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227835 Gregory Sargen One Meadowlands Plaza
East Rutherford NJ 07073
Evp, Corporate Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-07 30,000 $0.00 50,000 No 4 A Direct
Common Stock Disposition 2017-02-07 30,000 $54.88 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Pursuant to settlement of a performance share award
  2. Broker-assisted sale of which 15,135 shares sold were to cover the payment of withholding tax liability arising from the settlement of performance share award
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.68 to $55.15 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4